Active Ingredient(s):Ecallantide FDA Approved: * November 27, 2009 Pharm Company: *DYAX CORP.
Ecallantide (trade name Kalbitor) is a drug used for the treatment of hereditary angioedema (HAE) and in the prevention of blood loss in cardiothoracic surgery. It is an inhibitor of the protein kallikrein and a 60-amino acid polypeptide which was developed from a Kunitz domain through phage display to mimic antibodies inhibiting kallikrein.
1 Medical uses
2 Adverse effects
4 Mechanism of action
5 See also
* May have multiple approval dates, manufacturers, or labelers.